Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

404
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
404
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

325
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
325
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

482
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
482
Angina IV: Management01:26

Angina IV: Management

347
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
347
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

400
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
400

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Humidity-dependent dielectric and electrical behavior of strontium iron vanadate ceramics.

Nanoscale advances·2026
Same author

Pulmonary Hypertension, the Forgotten Right Ventricle, and Vascular Access in Hemodialysis Patients.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Humidity-dependent dielectric and electrical behavior of magnesium iron vanadate (Mg<sub>2</sub>FeVO<sub>6</sub>) ceramics.

RSC advances·2026
Same author

Unleashing potential: assessing Africa's readiness for the data science revolution to impact health.

Nature communications·2026
Same author

Harnessing data science for health discovery and innovation in Africa (DS-I Africa).

Communications medicine·2026
Same author

Pathways, outputs and impact of NIH-supported bioinformatics and genomics graduate trainees in Africa.

Briefings in bioinformatics·2026

Related Experiment Video

Updated: Feb 24, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

6.0K

Peripheral interventions and antiplatelet therapy: Role in current practice.

Pahul Singh1, Yenal Harper1, Carrie S Oliphant1

  • 1Pahul Singh, Yenal Harper, Mohamed Morsy, Raza Askari, Rami N Khouzam, Department of Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN 38163, United States.

World Journal of Cardiology
|August 22, 2017
PubMed
Summary

Peripheral arterial disease (PAD) management requires careful consideration of revascularization strategies. This review examines antiplatelet and anticoagulant therapy roles in lower limb PAD patients post-revascularization.

Keywords:
Antiplatelet therapyPeripheral arterial diseasePeripheral vascular diseaseRevascularization

More Related Videos

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.3K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.7K

Related Experiment Videos

Last Updated: Feb 24, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

6.0K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.3K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.7K

Area of Science:

  • Vascular Medicine
  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Peripheral arterial disease (PAD) is a prevalent condition linked to significant cardiovascular mortality, often underdiagnosed.
  • Key risk factors for PAD overlap with those for coronary and cerebrovascular diseases.
  • Current management involves exercise, pharmacotherapy, and revascularization (endovascular or surgical), with ongoing debate on optimal strategies.

Purpose of the Study:

  • To review current data on revascularization techniques for lower limb PAD.
  • To elucidate the role and optimal duration of antiplatelet and anticoagulant therapies post-revascularization in PAD.
  • To address the paucity of specific guidelines and studies for antiplatelet therapy in PAD.

Main Methods:

  • Literature review of current data on PAD revascularization.
  • Analysis of antiplatelet and anticoagulant therapy efficacy and safety in PAD.
  • Examination of evidence extrapolation from coronary and cerebrovascular interventions.

Main Results:

  • Endovascular interventions are increasingly utilized but face challenges like re-occlusion and thrombosis.
  • Platelet activation post-angioplasty is a critical factor in restenosis and thrombosis.
  • Data on antiplatelet therapy in PAD is limited, often relying on extrapolation from other cardiovascular diseases.

Conclusions:

  • Optimal revascularization strategy (endovascular vs. surgical) requires further head-to-head studies.
  • Evidence-based guidelines for antiplatelet and anticoagulant therapy duration in PAD are needed.
  • Further research is crucial to optimize medical and interventional management of lower limb PAD.